Quantitative and qualitative changes of apolipoprotein AI-containing lipoproteins in patients on continuous ambulatory peritoneal dialysis

Metabolism: Clinical and Experimental
T OhtaI Matsuda

Abstract

Using immunoaffinity chromatography, two species of apo-AI containing lipoproteins (AILp); lipoprotein containing apo-AI and apo-AII (Lp-AI/AII), and lipoprotein containing apo-AI, but no apo-AII (Lp-AI) were isolated from 13 female patients on continuous ambulatory peritoneal dialysis (CAPD), then characterized. The results were compared with findings obtained in agematched normolipidemic (control I) and mild hypertriglyceridemic (control II) female subjects. In comparison with control I: In AILp, the levels of total cholesterol (TC), cholesteryl ester (CE) and phospholipid (PL), and the levels of apoE were significantly lower in the CAPD patients while the levels of triglyceride (TG) and apo-CIII were significantly higher in these patients. The levels of apo-AI and apo-AII did not differ between the CAPD and control subjects. In Lp-AI/AII, changes of TC, CE, PL, TG, and apolipoproteins were similar to those of AILp, except for the ratio of apo-AI/apo-AII and the level of apo-CII, which was higher in the CAPD patients. In Lp-AI, changes of TC, CE, PL, and TG were also similar to those of AILp and Lp-AI/AII, but the apo-AI level was significantly lower in the CAPD patients. In comparison with control II: In AILp, the levels of ...Continue Reading

References

Oct 1, 1978·European Journal of Clinical Investigation·K BolzanoF Sandhofer
Feb 5, 1976·The New England Journal of Medicine·G G RhoadsA Kagan
Sep 1, 1976·The Journal of Clinical Investigation·R L HamiltonR J Havel
Feb 1, 1978·The Journal of Clinical Investigation·P H GreenR M Glickman
Nov 30, 1978·The New England Journal of Medicine·A R Tall, D M Small
Jul 1, 1979·The Journal of Clinical Investigation·P H GreenA R Tall
Jan 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·T OhtaI Matsuda
Jan 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J Rubiés-PratL Pira
Apr 26, 1973·The New England Journal of Medicine·E G LowrieJ P Merrill
Mar 28, 1974·The New England Journal of Medicine·A LindnerB H Scribner
Jan 1, 1983·Annual Review of Physiology·C L Bisgaier, R M Glickman
Dec 9, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·T Ohta, I Matsuda
Aug 5, 1982·The New England Journal of Medicine·P J NestelM H Tan

❮ Previous
Next ❯

Citations

Feb 1, 1991·European Journal of Clinical Investigation·G LucJ C Fruchart
Mar 29, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Jeffrey M Saland, Henry N Ginsberg
Mar 13, 2019·International Journal of Molecular Sciences·Agnieszka KuchtaMaciej Jankowski
Oct 30, 1992·Biochimica Et Biophysica Acta·M C CheungD R Illingworth
Feb 1, 1994·Kidney International·S HörkköY A Kesäniemi
Feb 1, 1993·Kidney International·J JovenJ D Brunzell

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.